Clinical Trial Update: Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial evaluating SYL1001 for ocular pain and dry eye syndrome has completed, assessing safety and effect. The study focused on safety and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Ocular Pain

Drugs mentioned

• SYL1001

Snippet

Sponsor: Sylentis, S.A. | Conditions: Ocular Pain, Dry Eye Syndrome | Phase 2 | Status: COMPLETED